ResearcherUniversity of Chieti-PescaraNo recent work listed
Rosa Amoroso
Matched on ORCID iD 0000-0002-8282-8535; OpenAlex author ID A5024010233. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 4
- Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. Co-author DOI 10.3390/ijms24031977↗
- Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Tar… Co-author DOI 10.3390/ph15080937↗
- The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer. Co-author DOI 10.3390/cancers11122042↗
- Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic cancer cell lines. Last author DOI 10.1111/cbdd.13026↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Rosalba Florio · 4 shared papers, 2017–2023 · strength 0.44
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Paper The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Panc… DOI 10.3390/cancers11122042↗
- Laura De Lellis · 4 shared papers, 2017–2023 · strength 0.44
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Paper The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Panc… DOI 10.3390/cancers11122042↗
- Alessandro Cama · 4 shared papers, 2017–2023 · strength 0.44
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Paper The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Panc… DOI 10.3390/cancers11122042↗
- Serena Veschi · 2 shared papers, 2019–2023 · strength 0.24
- Paper Resveratrol Derivative Exhibits Marked Antiproliferative Actions, Affecting Stemness in Pancreatic Cancer Cells. DOI 10.3390/ijms24031977↗
- Paper The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Panc… DOI 10.3390/cancers11122042↗
- Alessandra Ammazzalorso · 2 shared papers, 2017–2022 · strength 0.20
- Paper Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structu… DOI 10.3390/ph15080937↗
- Paper Cytotoxic effect of a family of peroxisome proliferator-activated receptor antagonists in colorectal and pancreatic can… DOI 10.1111/cbdd.13026↗
- Davide Brocco · 1 shared paper, 2023 · strength 0.16
- Paola Lanuti · 1 shared paper, 2023 · strength 0.16
- Nicola Tinari · 1 shared paper, 2019 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.